BSc (Hons) Biomedical Science
Biomedical scientists are at the forefront of diagnosing and treating diseases. Our biomedical science degree will give you the lab and research skills to help drive modern medicine.
Biography
Amr completed his doctorate degree study at the University of Oxford where he obtained a DPhil in Molecular Medicine from the Oxford Institute of Molecular Medicine in 2006. He then continued his research at Oxford, exploring novel genetic methods for the discovery of new therapies and worked in several research and teaching roles at Oxford University.
His research and teaching interest centres around understanding the relationship between genes and diseases. He has pioneered several gene silencing technologies for gene therapy applications. In his teaching at Oxford, he taught undergraduate and graduate students and adult learners in areas around gene therapy and personalised medicine.
Amr then joined Solent University in March 2022 after a substantial experience with the Oxford Medical Science that he had gained over the two decades he spent at Oxford.
Based on the strong academic team at Solent and the University’s state-of-the-art teaching laboratories and resources, Amr’s vision for biomedical science at Solent is to establish a world-class centre for learning and training on cutting-edge technologies in the ever fast-advancing biomedical science field.
Further information
Personalised Medicine in Brain Tumours
The aspect of 'personalised medicine' often mentioned over the last decade is purely depending on how far we can go in understanding patient’s individualised presentation of a given disease.
It is then the aspect of 'personalised disease' that must be addressed and established first before embarking on personalised medicine treatment options. Brain tumours are a class of cancer that have the poorest type of investigations and hence created as significant number of limitations in treating this very deadly disease.
Amr is interested in establishing brain tumour personalised disease models based on a patient’s specific tumour, studying the cancer from its source directly from patients through establishing and characterising patient-specific primary cell lines. The next step is to investigate the molecular interactions within these models with the view of attempting to identify novel therapeutic targets.Â
Taught courses
